Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09NFX
|
|||
| Former ID |
DNC010428
|
|||
| Drug Name |
Nicotinaldehyde O-4-propoxyphenylcarbamoyl oxime
|
|||
| Synonyms |
CHEMBL598545; nicotinaldehyde O-4-propoxyphenylcarbamoyl oxime
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H17N3O3
|
|||
| Canonical SMILES |
CCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CN=CC=C2
|
|||
| InChI |
1S/C16H17N3O3/c1-2-10-21-15-7-5-14(6-8-15)19-16(20)22-18-12-13-4-3-9-17-11-13/h3-9,11-12H,2,10H2,1H3,(H,19,20)/b18-12+
|
|||
| InChIKey |
RKEOSRSRXNLQCF-LDADJPATSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.